Item Type | Name |
Concept
|
Small Cell Lung Carcinoma
|
Academic Article
|
Gene mutations in primary tumors and corresponding patient-derived xenografts derived from non-small cell lung cancer.
|
Academic Article
|
Clinical Prediction of Pathologic Complete Response in Superior Sulcus Non-Small Cell Lung Cancer.
|
Academic Article
|
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy
|
Academic Article
|
Image analysis-based assessment of PD-L1 and tumor-associated immune cells density supports distinct intratumoral microenvironment groups in non-small cell lung carcinoma patients
|
Academic Article
|
Lack of Association Between Dexamethasone and Long-Term Survival After Non-Small Cell Lung Cancer Surgery.
|
Academic Article
|
Image Analysis-based Assessment of PD-L1 and Tumor-Associated Immune Cells Density Supports Distinct Intratumoral Microenvironment Groups in Non-small Cell Lung Carcinoma Patients.
|
Academic Article
|
Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.
|
Academic Article
|
Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base.
|
Academic Article
|
Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients.
|
Academic Article
|
The Influence of Body Mass Index on Overall Survival?Following Surgical Resection of Non-Small Cell Lung Cancer.
|
Academic Article
|
Long-Term Outcomes of Salvage Stereotactic Ablative?Radiotherapy for Isolated Lung Recurrence of Non-Small Cell Lung Cancer: A Phase II Clinical Trial.
|
Academic Article
|
Reply to "Influence of Body Mass Index on Overall Survival Following Surgical Resection of Non-Small Cell Lung Cancer: Methodological Issues".
|
Academic Article
|
Prophylactic Cranial Irradiation Following Surgical Resection of Early-Stage Small-Cell Lung Cancer: A Review of the Literature.
|
Academic Article
|
Programmed Death Cell Ligand 1 (PD-L1) Is Associated With Survival in Stage I Non-Small Cell Lung Cancer.
|
Academic Article
|
Development and Validation of a Predictive Radiomics Model for Clinical Outcomes in Stage I Non-small Cell Lung Cancer.
|
Academic Article
|
Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.
|
Academic Article
|
Development of an Immune-Pathology Informed Radiomics Model for Non-Small Cell Lung Cancer.
|
Academic Article
|
Immunohistochemical and Image Analysis-Based Study Shows That Several Immune Checkpoints are Co-expressed in Non-Small Cell Lung Carcinoma Tumors.
|
Academic Article
|
Prognostic Value of PD-L1 mRNA Sequencing Expression Profile in Non-Small Cell Lung Cancer.
|
Academic Article
|
Induction Cisplatin Docetaxel Followed by Surgery and Erlotinib in Non-Small Cell Lung Cancer.
|
Academic Article
|
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of non-small cell lung cancer (NSCLC).
|
Academic Article
|
Perioperative Outcomes for Stage I Non-Small Cell Lung Cancer: Differences Between Men and Women.
|
Academic Article
|
Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm.
|
Academic Article
|
Enhanced recovery after thoracic surgery is associated with improved adjuvant chemotherapy completion for non-small cell lung cancer.
|
Academic Article
|
Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience.
|
Academic Article
|
Local Consolidative Therapy Vs. Maintenance Therapy or Observation for Patients With Oligometastatic Non-Small-Cell Lung Cancer: Long-Term Results of a Multi-Institutional, Phase II, Randomized Study.
|
Academic Article
|
Persistent opioid use is associated with worse survival after lobectomy for stage I non-small cell lung cancer.
|
Academic Article
|
Tumor characteristics associated with engraftment of patient-derived non-small cell lung cancer xenografts in immunocompromised mice.
|
Academic Article
|
Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer.
|
Academic Article
|
Time Trends of Perioperative Outcomes in Early Stage Non-Small Cell Lung Cancer Resection Patients.
|
Academic Article
|
Commentary: Surgery for N3 non-small cell lung cancer-utopia or future reality?
|
Academic Article
|
Commentary: Neoadjuvant checkpoint inhibitors in resectable non-small cell lung cancer-Ready for prime time?
|
Academic Article
|
Surveillance After Treatment of Non-Small-Cell Lung Cancer: A Call for Multidisciplinary Standardization.
|
Academic Article
|
Comprehensive T cell repertoire characterization of non-small cell lung cancer.
|
Academic Article
|
Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients.
|
Academic Article
|
A Phase I/II Study of Neoadjuvant Cisplatin, Docetaxel, and Nintedanib for Resectable Non-Small Cell Lung Cancer.
|
Academic Article
|
Neutrophil expansion defines an immunoinhibitory peripheral and intratumoral inflammatory milieu in resected non-small cell lung cancer: a descriptive analysis of a prospectively immunoprofiled cohort.
|
Academic Article
|
Time trends and predictors of survival in surgically resected early-stage non-small cell lung cancer patients.
|
Academic Article
|
Peripheral cytokines are not influenced by the type of surgical approach for non-small cell lung cancer by four weeks postoperatively.
|
Academic Article
|
Perioperative considerations for neoadjuvant immunotherapy in non-small cell lung cancer.
|
Academic Article
|
Emerging Therapies in Thoracic Malignancies-Immunotherapy, Targeted Therapy, and T-Cell Therapy in Non-Small Cell Lung Cancer.
|
Academic Article
|
Perioperative outcomes among chronic opioid users who receive lobectomy for non-small cell lung cancer.
|
Academic Article
|
Predictors of survival following surgical resection of limited-stage small cell lung cancer.
|
Academic Article
|
Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer.
|
Academic Article
|
Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial.
|
Academic Article
|
Impact of Psychiatric Comorbidities on Surgical Outcomes for Non-Small Cell Lung?Cancer.
|
Academic Article
|
Will radiotherapy be a future part of neoadjuvant therapy in operable non-small-cell lung cancer?
|
Academic Article
|
Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer.
|
Academic Article
|
Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer.
|
Academic Article
|
The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics.
|
Academic Article
|
Preoperative and Postoperative Systemic Therapy for Operable Non-Small-Cell Lung Cancer.
|
Academic Article
|
Combined IL-2, agonistic CD3 and 4-1BB stimulation preserve clonotype hierarchy in propagated non-small cell lung cancer tumor-infiltrating lymphocytes.
|
Academic Article
|
Surgical outcomes after neoadjuvant nivolumab or nivolumab with ipilimumab in patients with non-small cell lung cancer.
|
Academic Article
|
Current Surgical Indications for Non-Small-Cell Lung Cancer.
|
Academic Article
|
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma.
|
Academic Article
|
Intraoperative challenges after induction therapy for non-small cell lung cancer: Effect of nodal disease on technical complexity.
|
Academic Article
|
Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non-Small-Cell Lung Cancer Data Set.
|
Academic Article
|
Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer.
|
Academic Article
|
Analysis of Immune Intratumor Heterogeneity Highlights Immunoregulatory and Coinhibitory Lymphocytes as Hallmarks of?Recurrence in Stage I Non-Small Cell Lung Cancer.
|
Academic Article
|
Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial.
|
Academic Article
|
The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer.
|
Academic Article
|
Predicting benefit from immune checkpoint inhibitors in patients with non-small-cell lung cancer by CT-based ensemble deep learning: a retrospective study.
|
Academic Article
|
Perioperative and oncologic outcomes of pulmonary resection for synchronous oligometastatic non-small cell lung cancer: Evidence for surgery in advanced disease.
|
Academic Article
|
Impact of travel distance on receipt of indicated adjuvant therapy in resected non-small cell lung cancer.
|
Academic Article
|
Surgical outcomes after chemotherapy plus nivolumab and chemotherapy plus nivolumab and ipilimumab in patients with non-small cell lung cancer.
|
Academic Article
|
NEOSTAR trial and the current status of neoadjuvant therapy in non-small cell lung cancer.
|
Academic Article
|
Circulomic variables predict pathologic staging preoperatively in treatment-na?ve non-small cell lung cancer.
|
Academic Article
|
Circulating tumor DNA and radiological tumor volume identify patients at risk for relapse with resected, early-stage non-small-cell lung cancer.
|
Academic Article
|
Transitioning to Neoadjuvant Therapy for Resectable Non-Small Cell Lung Cancer: Trends and Surgical Outcomes in a Regionalized Pulmonary Oncology Network.
|